King-Kallimanis, Bellinda L.
Wroblewski, Tanya
Kwitkowski, Virginia
De Claro, R. Angelo
Gwise, Thomas
Bhatnagar, Vishal
Farrell, Ann T.
Kluetz, Paul G.
Article History
Accepted: 12 February 2020
First Online: 25 February 2020
Compliance with ethical standards
:
: The authors declare no competing financial interests.
: IRB: This is US Government work and is a secondary analysis of data that was submitted to the Food and Drug Administration, therefore, IRB was not applicable. The trial identifier is NCT02195869.